Revelation Biosciences(REVB) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Revelation Biosciences, Inc. Announces Financial Results for the three and nine months ended September 30, 2025 San Diego, CA – November 6, 2025 – Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical- stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its financial results for the three and nine months ended September 30, 2025. Corporate Highlights "The outstanding PRIME data and subsequent financing vali ...